Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer

  • Bin Zhang

Press/Media: Press / Media

PeriodMay 20 2021

Media coverage

1

Media coverage

  • TitleOncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date05/20/21
    PersonsBin Zhang